Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Current Assets

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Current Assets (Including Current Investments) ₹211 Cr₹168 Cr₹69 Cr₹62 Cr₹28 Cr

What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) is ₹211 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹211 Cr
Mar2024₹168 Cr
Mar2023₹69 Cr
Mar2022₹62 Cr
Mar2017₹28 Cr

How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Current Assets % Change
Mar2025 ₹211 Cr
25.20
Mar2024 ₹168 Cr
145.53
Mar2023 ₹69 Cr
11.35
Mar2022 ₹62 Cr
122.16
Mar2017 ₹28 Cr -

Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,062.2 Cr -2.3% -11.5% -33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-2.3%

-11.5%

-33.6%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses